Comparative analysis of organic magnesium salts: clinical and pharmacological aspects

Magnesium deficiency is a widespread problem associated with an increased risk of cardiovascular, neurological, and metabolic disorders. The effectiveness of magnesium therapy is largely determined by the bioavailability of the salt used. It is well known that magnesium salts with organic anions are characterized by relatively high bioavailability. This paper presents a detailed analysis of the pharmacological properties of organic magnesium salts: magnesium malate, fumarate, citrate, aspartate, glycinate, threonate, pyroglutamate, orotate, and lactate. The article examines the structural features, elemental magnesium content, anion metabolism, and the effect of anions in the salt on the bioavailability and biodistribution of Mg²⁺. The feasibility of personalized selection of magnesium salts based on clinical needs is substantiated.

1. de Baaij JH, Hoenderop JG, Bindels RJ. Magnesium in man: implications for health and disease. Physiol Rev. 2015 Jan;95(1):1-46. doi: 10.1152/physrev.00012.2014.

2. Passarelli S, Free CM, Shepon A, et al. Global estimation of dietary micronutrient inadequacies: a modelling analysis. Lancet Glob Health. 2024 Oct;12(10):e1590-e1599. doi: 10.1016/S2214-109X(24)00276-6.

3. Wang X, Dou Z, Feng S, et al. Global food nutrients analysis reveals alarming gaps and daunting challenges. Nat Food. 2023 Nov;4(11):1007-1017. doi: 10.1038/s43016-023-00851-5.

4. Shikh EV, Makhova AA, Chemeris AV, Tormyshov IA. [Iatrogenic deficits of micronutrients]. Vopr Pitan. 2021;90(4):53-63. Russian. doi: 10.33029/0042-8833-2021-90-4-53-63.

5. Gromova OA, Torshin IYu, Moiseev VS, Sorokina MA. On the pharmacological interactions of antibiotics with magnesium and on the magnesium deficiency arising as a result of antibiotic treatment. Therapy. 2017;11(1):135-143. (In Russ.).

6. Lameris AL, Monnens LA, Bindels RJ, Hoenderop JG. Drug-induced alterations in Mg2+ homoeostasis. Clin Sci (Lond). 2012 Jul;123(1):1-14. doi: 10.1042/CS20120045.

7. Adomako EA, Yu ASL. Magnesium Disorders: Core Curriculum 2024. Am J Kidney Dis. 2024 Jun;83(6):803-815. doi: 10.1053/j.ajkd.2023.10.017.

8. Firoz M, Graber M. Bioavailability of US commercial magnesium preparations. Magnes Res. 2001 Dec;14(4):257-62.

9. Uysal N, Kizildag S, Yuce Z, et al. Timeline (Bioavailability) of Magnesium Compounds in Hours: Which Magnesium Compound Works Best? Biol Trace Elem Res. 2019 Jan;187(1):128-136. doi: 10.1007/s12011-018-1351-9.

10. Gromova OA, Torshin IYu. Magnesium and "Civilization Diseases". Moscow: GEOTAR-Media, 2018. (In Russ.). ISBN 978-5-9704-4527-3.

11. Workinger JL, Doyle RP, Bortz J. Challenges in the Diagnosis of Magnesium Status. Nutrients. 2018 Sep 1;10(9):1202. doi: 10.3390/nu10091202.

12. Witkowski M, Hubert J, Mazur A. Methods of assessment of magnesium status in humans: a systematic review. Magnes Res. 2011 Dec;24(4):163-80. doi: 10.1684/mrh.2011.0292.

13. Gullestad L, Nes M, Rønneberg R, et al. Magnesium status in healthy free-living elderly Norwegians. J Am Coll Nutr. 1994 Feb;13(1):45-50. doi: 10.1080/07315724.1994.10718370.

14. Walker AF, Marakis G, Christie S, Byng M. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnes Res. 2003 Sep;16(3):183-91.

15. Abraham GE, Flechas JD. Management of fibromyalgia: rationale for the use of magnesium and malic acid. Journal of Nutritional Medicine. 1992;3(1):49-59. doi: 10.3109/13590849208997961

16. Kornberg MD, Bhargava P, Kim PM, et al. Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. Science. 2018 Apr 27;360(6387):449-453. doi: 10.1126/science.aan4665.

17. Schuette SA, Lashner BA, Janghorbani M. Bioavailability of magnesium diglycinate vs magnesium oxide in patients with ileal resection. JPEN J Parenter Enteral Nutr. 1994 Sep-Oct;18(5):430-5. doi: 10.1177/0148607194018005430.

18. Kawai N, Sakai N, Okuro M, et al. The sleep-promoting and hypothermic effects of glycine are mediated by NMDA receptors in the suprachiasmatic nucleus. Neuropsychopharmacology. 2015 May;40(6):1405-16. doi: 10.1038/npp.2014.326.

19. Slutsky I, Abumaria N, Wu LJ, et al. Enhancement of learning and memory by elevating brain magnesium. Neuron. 2010 Jan 28;65(2):165-77. doi: 10.1016/j.neuron.2009.12.026.

20. Dyckner T, Wester PO. The relation between extra- and intracellular electrolytes in patients with hypokalemia and/or diuretic treatment. Acta Med Scand. 1978;204(4):269-82. doi: 10.1111/j.0954-6820.1978.tb08438.x.

21. Classen HG. Magnesium orotate—experimental and clinical evidence. Rom J Intern Med. 2004;42(3):491-501. PMID: 16366126.

22. Gromova OA, Torshin IIu, Kalacheva AG, et al. Molecular mechanisms of pidolate magnesium action and its neurotropic affects. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(12):96-103. (In Russ.). doi: 10.17116/jnevro201611612196-103.

23. Lindberg JS, Zobitz MM, Poindexter JR, Pak CY. Magnesium bioavailability from magnesium citrate and magnesium oxide. J Am Coll Nutr. 1990 Feb;9(1):48-55. doi: 10.1080/07315724.1990.10720349.

24. Parra M, Stahl S, Hellmann H. Vitamin B6 and Its Role in Cell Metabolism and Physiology. Cells. 2018 Jul 22;7(7):84. doi: 10.3390/cells7070084.

25. Gromova OA, Torshin IY, Tapilskaya NI. Proteomic analysis of magnesium-dependent proteins and children’s health. Meditsinskiy sovet = Medical Council. 2017;(1):66-76. (In Russ.). doi: 10.21518/2079-701X-2017-1-66-76.